is glp-1 safe for kidneys and the kidney: from physiology to pharmacology and outcomes in diabetes GLP-1 receptor agonists and next-generation

"With tens of millions of customer touch points annually in the closed-loop provider network, we are amassing a powerful data set that is becoming harder to replicate

9 reports of biliopancreatic bypass with/without duodenal switch showed 74.1% EWL

This framework explains why some patients see dramatic improvements while others see modest changes

This article examines the evidence, mechanisms, symptoms, and management strategies for gallbladder issues related to GLP-1 therapy

Wondr Health, Jan

Dipeptidyl peptidase 4 inhibitor use is associated with a lower risk of incident acute kidney injury in patients with diabetes